NCT03242434 Investigation of Thermal Injury on Intestinal Permeability in Both Thermal Injury and Healthy Participants Status TERMINATED Phase PHASE1
NCT03239600 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS) Status WITHDRAWN Phase PHASE2
NCT03238352 A Study to Assess Efficacy of an Experimental Oral Rinse in Providing Long Term Relief From Dentinal Hypersensitivity Status COMPLETED Phase PHASE2
NCT03235726 Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the Drug Status COMPLETED Phase PHASE1
NCT03234036 A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir Status COMPLETED Phase PHASE1
NCT03233009 To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch Test Status COMPLETED Phase NA
NCT03231943 GSK3640254 First Time in Human (FTIH) Study in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03227445 Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE4
NCT03219255 RELVAR® 100 ELLIPTA® Special Drug Use Investigation (COPD, Long-term) Status COMPLETED Phase N/A
NCT03216265 A Proof of Concept Clinical Study to Investigate the Effects of an Experimental Cosmetic Moisturiser on the Barrier Function of Human Skin on the Face and Forearm Status COMPLETED Phase NA
NCT03212690 Study of Renin-angiotensin System in Mechanically Ventilated Subjects Status TERMINATED Phase NA
NCT03207958 Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation Status COMPLETED Phase PHASE1
NCT03207750 This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine Status COMPLETED Phase PHASE3
NCT03207347 A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) Status COMPLETED Phase PHASE2
NCT03207243 Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma Status COMPLETED Phase PHASE2
NCT03202004 GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis Status WITHDRAWN Phase PHASE3